TABLE 2.

Various angiogenesis-related lncRNAs in GBM.

LncRNAs	Loci	Expression status	Targets	Model (in vitro, in vivo, human)	Kind of cells	Reference
SLC26A4-AS1	chr7: q22.3–q22.3	Down	NPTX1	Humans, in vitro, In vivo	T98G, HS683, U251	Yu et al., 2020
PAXIP1-AS1	chr7: q36.2–q36.2	Up	ETS1	Human, in vitro, in vivo	TJ905, HS 683, H4, SHG-44, Has	Xu H. et al., 2019
SNHG15	chr7: p13–p13	Up	miR-153	Human, in vitro, in vivo	hCMECs	Ma et al., 2017
TUG1	chr22: q12.2–q12.2	Up	miR-299 (VEGFA)	Human, in vitro, in vivo	U251 MG, U87MG, HEK293T	Cai et al., 2017
lncRNA-LINC01116	–	Up	VEGFA	Human, in vitro, in vivo	U251, A172, U87MG, U118MG, HUVEC, HEK293T	Ye et al., 2020
lncRNA H19	chr11: p15.5–p15.5	Up	miR-29a	Human, in vitro, in vivo	HBMVEC	Jia et al., 2016
lncRNA H19	chr11: p15.5–p15.5	Up	miR-138/HIF-1α/VEGF138/HIF-1α	In vitro	U87, A172, U373, HEB	Liu et al., 2019
MCM3AP-AS1	chr21: q22.3–q22.3	Up	miR-211 (KLF5 and AGGF1)	In vitro, in vivo	hCMEC/D3, U87, HEK293T	Yang et al., 2018
SBF2-AS1	chr11: p15.1	Up	miR-338-3p, EGFL7	Human, in vitro, in vivo	U87, U118, HEK293T	Yu et al., 2017